<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00158</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <TABLE>  <!-- PJG tableformat 4,L2,i1,s50,r100,r100,r150 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> Table 2._Criteria for Determining Adequacy of Existing Data in Lieu of Tier 2 (T2) Tests  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Endpoint  <!-- PJG 007 0150 intable --> 1T2 testing in the absence of adequate existing data  <!-- PJG 007 0150 intable --> 1Minimum requirements for existing data to be considered adequate substitutes for T2 tests  <!-- PJG 007 0150 intable --> 1Examples of other existing studies which may be acceptable <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=4 --> Carcinogenicity  <!-- PJG 007 0104 intable --> Salmonella assay,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> in vivo <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 -->  Micronucleus assay, and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> in vivo <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 -->  Sister Chromatid Exchange assay  <!-- PJG 007 0104 intable --> Salmonella assay plus two other assays (at least one of which shall be  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> in vivo <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> )  <!-- PJG 007 0104 intable --> Alternative to all assays: Lifetime cancer study.  <!-- PJG 007 0120 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> In vivo <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 -->  assays: Sister Chromatid Exchange (SCE), Chromosomal Aberrations (CA), Micronucleus (MN), Unscheduled DNA Synthesis (UDS).  <!-- PJG 007 0120 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> In vitro <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 -->  or microbial assays:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> E. coli <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 -->  Reverse Mutation, DNA Repair, Yeast Mutation, Yeast Mitotic Recombination, Mouse Lymphoma, CHO/V79 Mutation, UDS, CA, SCE, Cell Transformation. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Mutagenicity  <!-- PJG 007 0104 intable --> Salmonella assay and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> in vivo <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 -->  Micronucleus assay  <!-- PJG 007 0104 intable --> Salmonella assay plus one  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=3 --> in vivo <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 -->  assay  <!-- PJG 007 0104 intable --> MN, Dominant Lethal Assay, CA, Heritable Translocation Assay, Specific Locus Assay. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Teratogenicity  <!-- PJG 007 0104 intable --> T2 fertility/teratology assessment with 90-day exposure  <!-- PJG 007 0104 intable --> FDA/Phase II (gd6&hyph;15) Study  <!-- PJG 007 0104 intable --> If fetal effects analysis is included: Two-generation study, Reproductive Assessment by Continuous Breeding (RACB), One-generation study. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Adult reproductive effects  <!-- PJG 007 0104 intable --> T2 fertility/teratology assessment with 90-day exposure  <!-- PJG 007 0104 intable --> T2 fertility/teratology assessment with 90-day exposure  <!-- PJG 007 0104 intable --> Two-generation study, Reproductive Assessment by Continuous Breeding (RACB), One-generation study. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Neurotoxicity  <!-- PJG 007 0104 intable --> GFAP assay and neuro-histopathology with 90-day exposure  <!-- PJG 007 0104 intable --> GFAP assay and neuro-histopathology with 90-day exposure  <!-- PJG 007 0104 intable --> Detailed characterization of neurotoxicity using behavior, neurophysiological, and/or neurochemical assessments (e.g., EPA Neurotoxicity Assessment). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Pulmonary effects  <!-- PJG 007 0104 intable --> T2 respiratory tract pathology after 90-day exposure  <!-- PJG 007 0104 intable --> T2 respiratory tract pathology after 90-day exposure  <!-- PJG 007 0104 intable --> Chronic toxicity study, with or without lifetime cancer study; subchronic toxicity study. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            